Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2 with no changes to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page. This change does not alter the study details, eligibility criteria, or results.SummaryDifference0.3%

- Check34 days agoChange DetectedThe study record now includes posted results with a new 'Results First Posted' date (2025-01-27) and updated QC-related study dates.SummaryDifference0.3%

- Check63 days agoChange DetectedUpdate: page version bumped to v3.2.0 with an added government operating status notice; removal of the v3.1.0 tag. Overall, signals a status and version update rather than a change to core content.SummaryDifference2%

- Check70 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.0%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, indicating a minor update; the 'Back to Top' navigation element was removed.SummaryDifference0.1%

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.